Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

A groundbreaking stem cell therapy offers new hope for type 1 diabetes, with early results showing potential for insulin ...

The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies ...

Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

A recent study suggests that type 2 diabetes can be reversed through a combination of calorie reduction, physical activity, ...

Learn how diabetes medications could revolutionize stroke prevention and enhance heart and brain health with breakthrough ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...

A thorough examination of modern drugs that target particular receptors and metabolic pathways for glucose and fat metabolism is presented. Recent research has revealed innovative targets and ...

Anti-inflammatory drugs were linked to a reduced risk of dementia. Antibiotics, antivirals and vaccines, such as for ...